For the first time, Ministry of Food and Drug Safety (MFDS) officially announced its investigation on possibility of finding NDMA carcinogen in nizatidine, a structurally similar substance to ranitidine.

Director Kim Nam-Soo of Pharmaceutical Management Division at MFDS convened a press conference on Oct. 29 and shared the news. The Pharmaceutical Management Division previously led the NDMA investigation on ranitidine drugs. The division had kept the investigation unannounced, despite news media’s flooding inquiries.

The same happened with the nizatidine investigation. Many suspected the Pharmaceutical Management Division would lead the investigation, but the division never men